ATTY Table 4 (cont'd) Patient No. & sex Age at surgery Years post exposure Pathologic diagnosis Remarks Utirik exposed 2229 F 32 15 1/2 Follicular carcinoma Divided opinion: 2208 F 2212 F 53 53 19 19 Adenomatous nodules Adenomatous nodules with Hiirthle cell Hyperplasia 2221 f° 73 19 Adenomatous nodules with follicular Hyperplasia, focal atypia 2160 F 25 21 1/2 Papillary carcinoma Hyperplasia 2150 M 2194 F 2261x M 2236 M 2193 F 2195 F 2215 F 2147 2196 2239 2132 F F F F 34 59 50 35 56 22 22 23 1/2 adenoma Follicular adenoma Papillary carcinoma No diagnostic lesion Lymph node metastases Follicular adenoma Adenomatous nodules Focal hyperplasia Papillary hyperplasia 33 41 4l Adenomatous nodule Adenomatous nodule Adenomatous nodules Papillary hyperplasia 66 28 50 44 34 Papillary carcinoma Fibrosis, hyperplasia Adenomatous nodule Adenomacous nodule Fibrosis Papillary hyperplasia 49 58 30 63 29 28 24 25 1/2 adenoma atypical adenoma 25 1/2 25 1/2 25 1/2 26 1/2 27 27 Adenomatous nodule Adenomatous nodules with occult papillary carcinoma Adenomatous nodules Diffuse Adenomatous nodules Adenomatous nodules Adenomatous nodule Fibrosis Rongelap unexposed controls ¢38 F 829 F 841 F 1007 1573 867 4023 1556 M M F F F with occult papillary care inoma Papillary carcinoma No diagnostic lesion - 65 -